Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC · 2012
Fertility treatment decision-making: the effect of insurance coverage for fertility medications.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Jones Claire Ann, Gray Laura, Liu Kimberly
Аннотация
OBJECTIVE: To analyze the perceived impact of insurance coverage for fertility medications on patients' fertility treatment decision-making.
METHODS: We conducted a cross-sectional study involving a patient survey and chart review of women at a Canadian university-affiliated fertility centre. The primary outcome was to determine whether women with self-reported insurance coverage for fertility medications perceived the impact of insurance coverage for fertility medications differently from women without coverage or those who do not know their extent of coverage. Secondary outcomes included differences between groups in the perceived impact of insurance coverage for fertility medications on specific treatment decisions and the type of fertility treatments undergone by patients. Data collected from the survey and chart review were analyzed using chi-square tests.
RESULTS: More women without insurance ranked insurance coverage as having a large impact on the decision to undergo fertility treatment than women in the other groups, although this was not statistically significant. Significantly more women without insurance coverage ranked all specific treatment decisions except for the number of IVF cycles as having a large impact than did women in the other groups.
CONCLUSION: Women perceive that having insurance coverage for fertility medications affects the decision to undergo fertility treatment. Women without insurance are more likely to perceive that insurance coverage affects specific fertility treatment decisions than women with insurance or women who do not know whether they have insurance.
METHODS: We conducted a cross-sectional study involving a patient survey and chart review of women at a Canadian university-affiliated fertility centre. The primary outcome was to determine whether women with self-reported insurance coverage for fertility medications perceived the impact of insurance coverage for fertility medications differently from women without coverage or those who do not know their extent of coverage. Secondary outcomes included differences between groups in the perceived impact of insurance coverage for fertility medications on specific treatment decisions and the type of fertility treatments undergone by patients. Data collected from the survey and chart review were analyzed using chi-square tests.
RESULTS: More women without insurance ranked insurance coverage as having a large impact on the decision to undergo fertility treatment than women in the other groups, although this was not statistically significant. Significantly more women without insurance coverage ranked all specific treatment decisions except for the number of IVF cycles as having a large impact than did women in the other groups.
CONCLUSION: Women perceive that having insurance coverage for fertility medications affects the decision to undergo fertility treatment. Women without insurance are more likely to perceive that insurance coverage affects specific fertility treatment decisions than women with insurance or women who do not know whether they have insurance.